Try our Advanced Search for more refined results

Expert Analysis

FDA's Challenge To Implied Outcomes Of ADHD Drugs

Law360 (October 2, 2008, 12:00 AM EDT) -- In Warning Letters to two companies, and in Untitled Letters to three, the U.S. Food and Drug Administration's (FDA's) Division of Drug Marketing, Advertising, and Communications (DDMAC) on Sep. 25, 2008, alleged that promotional material for certain products intended for use in treating attention deficit hyperactivity disorder (ADHD) made implied claims about an effect on ADHD "outcomes" that were not supported by "substantial evidence," as that latter term is used in statutory parlance....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!